# TPG Mortgage Investment Trust, Inc.: financial statements, quarterly

MITT · NYSE · CIK 1514281 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mitt.md) · [Financials](/companies/mitt/financials.md) · [Filings](/companies/mitt/filings.md) · [Insiders](/companies/mitt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mitt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [52.7](/filings/0001514281-23-000145.md) | [64.2 d](/filings/0001514281-24-000033.md) | [78.4](/filings/0001514281-24-000086.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001514281-24-000155.md) | [0.0 d](/filings/0001514281-25-000026.md) | [0.0](/filings/0001514281-25-000062.md) | [0.0](/filings/0001514281-25-000086.md) | [0.0](/filings/0001628280-25-050624.md) | [0.1 d](/filings/0001628280-26-011775.md) | [0.0](/filings/0001628280-26-029382.md) | [0.0](/filings/0001628280-26-055328.md) | [0.7](/filings/0001628280-25-050624.md) | [0.1 d](/filings/0001628280-26-011775.md) | [0.2](/filings/0001628280-26-029382.md) | [0.2](/filings/0001628280-26-055328.md) |
| Net income | $m | [(2.2)](/filings/0001514281-24-000155.md) | [35.4 d](/filings/0001514281-25-000026.md) | [20.9](/filings/0001514281-25-000062.md) | [3.9](/filings/0001514281-25-000086.md) | [16.6](/filings/0001628280-25-050624.md) | [14.3 d](/filings/0001628280-26-011775.md) | [11.5](/filings/0001628280-26-029382.md) | [3.9](/filings/0001628280-26-055328.md) | [20.0](/filings/0001628280-25-050624.md) | [13.3 d](/filings/0001628280-26-011775.md) | [(3.6)](/filings/0001628280-26-029382.md) | [14.3](/filings/0001628280-26-055328.md) |
| Diluted EPS | $ per share | [(0.33)](/filings/0001514281-24-000155.md) | not reported | [0.55](/filings/0001514281-25-000062.md) | [(0.02)](/filings/0001514281-25-000086.md) | [0.40](/filings/0001628280-25-050624.md) | not reported | [0.21](/filings/0001628280-26-029382.md) | [(0.05)](/filings/0001628280-26-055328.md) | [0.47](/filings/0001628280-25-050624.md) | not reported | [(0.27)](/filings/0001628280-26-029382.md) | [0.29](/filings/0001628280-26-055328.md) |
| Basic EPS | $ per share | [(0.33)](/filings/0001514281-24-000155.md) | not reported | [0.55](/filings/0001514281-25-000062.md) | [(0.02)](/filings/0001514281-25-000086.md) | [0.40](/filings/0001628280-25-050624.md) | not reported | [0.21](/filings/0001628280-26-029382.md) | [(0.05)](/filings/0001628280-26-055328.md) | [0.47](/filings/0001628280-25-050624.md) | not reported | [(0.27)](/filings/0001628280-26-029382.md) | [0.29](/filings/0001628280-26-055328.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [119](/filings/0001514281-24-000155.md) | [112](/filings/0001514281-25-000026.md) | [100](/filings/0001514281-25-000062.md) | [121](/filings/0001514281-25-000086.md) | [103](/filings/0001628280-25-050624.md) | [119](/filings/0001628280-26-011775.md) | [116](/filings/0001628280-26-029382.md) | [88.7](/filings/0001628280-26-055328.md) | [59.0](/filings/0001628280-25-050624.md) | [57.8](/filings/0001628280-26-055328.md) | [49.3](/filings/0001628280-26-029382.md) | [61.6](/filings/0001628280-26-055328.md) |
| Total assets | $m | [4,882](/filings/0001514281-23-000145.md) | [6,126](/filings/0001514281-25-000026.md) | [6,401](/filings/0001514281-24-000086.md) | [7,100](/filings/0001514281-24-000118.md) | [6,960](/filings/0001514281-24-000155.md) | [6,914](/filings/0001628280-26-011775.md) | [7,323](/filings/0001514281-25-000062.md) | [7,462](/filings/0001514281-25-000086.md) | [8,976](/filings/0001628280-25-050624.md) | [8,712](/filings/0001628280-26-055328.md) | [8,288](/filings/0001628280-26-029382.md) | [7,936](/filings/0001628280-26-055328.md) |
| Total liabilities | $m | [4,431](/filings/0001514281-23-000145.md) | [5,598](/filings/0001514281-25-000026.md) | [5,861](/filings/0001514281-24-000086.md) | [6,567](/filings/0001514281-24-000118.md) | [6,420](/filings/0001514281-24-000155.md) | [6,370](/filings/0001628280-26-011775.md) | [6,779](/filings/0001514281-25-000062.md) | [6,926](/filings/0001514281-25-000086.md) | [8,416](/filings/0001628280-25-050624.md) | [8,151](/filings/0001628280-26-055328.md) | [7,744](/filings/0001628280-26-029382.md) | [7,390](/filings/0001628280-26-055328.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [450](/filings/0001514281-24-000155.md) | [528](/filings/0001628280-26-011775.md) | [540](/filings/0001514281-25-000086.md) | [534](/filings/0001628280-25-050624.md) | [540](/filings/0001628280-25-050624.md) | [543](/filings/0001628280-26-055328.md) | [544](/filings/0001628280-26-055328.md) | [536](/filings/0001628280-26-055328.md) | [560](/filings/0001628280-25-050624.md) | [561](/filings/0001628280-26-055328.md) | [544](/filings/0001628280-26-055328.md) | [546](/filings/0001628280-26-055328.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.0 d](/filings/0001514281-24-000155.md) | [10.0 d](/filings/0001514281-25-000026.md) | [12.0](/filings/0001514281-25-000062.md) | [13.7 d](/filings/0001514281-25-000086.md) | [14.5 d](/filings/0001628280-25-050624.md) | [15.7 d](/filings/0001628280-26-011775.md) | [12.0](/filings/0001628280-26-029382.md) | [11.5 d](/filings/0001628280-26-055328.md) | [17.4 d](/filings/0001628280-25-050624.md) | [18.7 d](/filings/0001628280-26-011775.md) | [20.3](/filings/0001628280-26-029382.md) | [24.2 d](/filings/0001628280-26-055328.md) |
| Dividends paid | $m | [3.6 d](/filings/0001514281-24-000155.md) | [6.3 d](/filings/0001514281-25-000026.md) | [1.5](/filings/0001514281-25-000062.md) | [5.3 d](/filings/0001514281-25-000086.md) | [5.6 d](/filings/0001628280-25-050624.md) | [5.6 d](/filings/0001628280-26-011775.md) | [5.6](/filings/0001628280-26-029382.md) | [5.9 d](/filings/0001628280-26-055328.md) | [6.2 d](/filings/0001628280-25-050624.md) | [6.7 d](/filings/0001628280-26-011775.md) | [7.3](/filings/0001628280-26-029382.md) | [7.6 d](/filings/0001628280-26-055328.md) |
| Share repurchases | $m | [0.0 d](/filings/0001514281-24-000155.md) | [0.0 d](/filings/0001514281-25-000026.md) | [0.0](/filings/0001514281-24-000086.md) | [0.0 d](/filings/0001514281-24-000118.md) | [0.0 d](/filings/0001514281-24-000155.md) | [0.0 d](/filings/0001514281-25-000026.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.4](/filings/0001514281-23-000145.md) | [21.1](/filings/0001514281-24-000086.md) | [20.2](/filings/0001514281-24-000118.md) | [20.2](/filings/0001514281-24-000155.md) | [29.5](/filings/0001514281-25-000062.md) | [29.5](/filings/0001514281-25-000086.md) | [29.5](/filings/0001628280-25-050624.md) | [29.7](/filings/0001628280-26-029382.md) | [29.7](/filings/0001628280-26-055328.md) | [31.1](/filings/0001628280-25-050624.md) | [31.7](/filings/0001628280-26-029382.md) | [31.8](/filings/0001628280-26-055328.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 31,803,475 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055328.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.